1,2,3,5-Tetra-O-Benzoyl-2’-C-Methyl-Beta-D-Ribofuranose

15397-15-6

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that ♦is market-oriented and realizes industrial developmeεnt through R&D innovation and technology transformation.

key word:

Pharmaceutical technology

Category:

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a large health i≠ndustry finance platform company integrating pharmaceutical, intelligent medical≠, bio pharmaceutical R&D, industrial production and sales.

The chemical reactions involved in the existing products include Foucault reλaction, nitration reaction, sulfonation reaction, hydrogenation react♠ion, fluorination reaction, chlorination reaction, bromination reπaction, diazotization reaction, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor dγeveloped by Merck. In October 2006, Sitagliptin phosphate Januvia was approved by FDA as the fir®st DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus. The characteristics oλf this drug are that it can stimulate insulin secr≈etion while reducing hunger without causing weight gain. Hypoglycemia and edema will not  occur, and it is suitable for diabetic patients with poor blood glucose control and freque∞nt hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterp♠rise that is market-oriented and realizes industrial development through R&D innovat'ion and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most↕ important products for the treatment of arthritis. It is wel↓l tolerated and has a low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three maγjor leukotriene receptor antagonists. In clinical application, it has good therapeutic effect on a÷topic asthma and other types of bronchial asthma, and the marke€t prospect is huge. In the major category of asthma drugs, leukotriene receptor antagonists haveλ the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is marke★t-oriented and realizes industrial development through R&D innovat©ion and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug approved ×by FDA for Alzheimer's disease in the United States. Its treatmen₹t reaches the target dose and has low toxic and side effects. It has been widely recognized by♠ our medical community, and good tolerance is its biggest advantage. In October 1999, Donepe✔zil was launched in China under the trade name "Aricept", whichσ is the main chemical drug against Alzheimer's disease. A↑t present, CFDA has approved a number of domestic enterprises to p roduce donepezil preparations, the main dosage forms are tablets, capsules, dispersive tablet's, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (¥Eliquis, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa ✘inhibitor, was approved for use in the 27 EU member states. The world's fαirst drug approved to prevent venous thromboembolism (VTE) in adult patients uΩndergoing elective hip or knee replacement. From June 2λ019 to June 2020, the annual sales of apixaban products overseas reached about $15.4 bi₹llion, with a year-on-year growth of nearly 32%, an♦d the API consumption reached about 23,960 kg, witλh a year-on-year growth of about 28%. Compared with its main compet itor, Rivaroxaban, the drug's annual overseas sales are about $4.5 bi®llion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmac×eutical enterprise that is market-oriented and realizes in‍dustrial development through R&D innovation and technology transformatio•n.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On D→ecember 29, 2004, it was approved by FDA for the treatment of refractory or relaps↑ed acute lymphoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharma±ceutical enterprise that is market-oriented and realizes industrial development through R&D inn•ovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other services, ≈E-mail: 2880705932@qq.com
Submit